Linking structure and function in the normal and in the disease human brain

Lead Research Organisation: University of Oxford
Department Name: Medical Sciences Division

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
 
Description Public consultation roll out of participant involvement in research- MRC/WT sponsorted
Geographic Reach National 
Policy Influence Type Participation in a advisory committee
Impact Changes in perception of clinical trials
 
Description Centre for Mathematics of Precision Healthcare
Amount £1,899,999 (GBP)
Funding ID EP/N014529/1 
Organisation Engineering and Physical Sciences Research Council (EPSRC) 
Sector Academic/University
Country United Kingdom
Start 10/2015 
End 09/2019
 
Description Dementias Platform
Amount £4,500,000 (GBP)
Funding ID MR/L023784/1 
Organisation Medical Research Council (MRC) 
Sector Academic/University
Country United Kingdom
Start 04/2014 
End 03/2019
 
Description MRC Experimental Medicine
Amount £897,903 (GBP)
Funding ID MR/N026934/1 
Organisation Medical Research Council (MRC) 
Sector Academic/University
Country United Kingdom
Start 10/2016 
End 09/2019
 
Description MS Society Project grant
Amount £175,000 (GBP)
Organisation Multiple Sclerosis Society 
Sector Charity/Non Profit
Country United Kingdom
Start 04/2003 
End 03/2006
 
Description OPTIMISE
Amount € 725,000 (EUR)
Organisation Biogen 
Sector Public
Country United Kingdom
Start 09/2014 
End 08/2017
 
Description Pilot Grant
Amount € 74,995 (EUR)
Organisation International Progressive MS Alliance 
Sector Charity/Non Profit
Country United Kingdom
Start 08/2014 
End 07/2015
 
Description Senior Investigator Award
Amount £450,000 (GBP)
Organisation National Institute for Health Research 
Department NIHR Biomedical Research Centre
Sector Academic/University
Country United Kingdom
Start 04/2015 
End 02/2020
 
Title FSL 
Description On line software analysis 
Type Of Material Improvements to research infrastructure 
Year Produced 2006 
Provided To Others? Yes  
Impact Widespread academic and pharmaceutical use 
 
Description Austrian Stroke Study 
Organisation Medical University of Graz
Department Department of Neurology
Country Austria 
Sector Academic/University 
PI Contribution Advanced analysis support; mentorship for trainees; interpretative framework
Collaborator Contribution Data. fellow for analysis
Impact Publications
 
Description FMRIB Centre Oxford 
Organisation John Radcliffe Hospital
Department Centre for Functional MRI of the Brain (fMRI)
Country United Kingdom 
Sector Hospitals 
PI Contribution Collaborative supervision of fellows and research
Collaborator Contribution Collaborative research, support for fellows and students, research environment
Impact Papers since 2006 with FMRIB coauthors
 
Description Stroke adaptive plasticity 
Organisation GlaxoSmithKline (GSK)
Department Neurology and GI Centre of Excellence for Drug Discovery (CEDD) GSK
Country United Kingdom 
Sector Private 
PI Contribution Proposed extenstion of current work as paradigm for evaluation of new drug targeting plasticity
Collaborator Contribution Provision of leadership, target objectives
Impact Publications
Start Year 2006
 
Description UK Biobank 
Organisation UK Biobank
Country United Kingdom 
Sector Charity/Non Profit 
PI Contribution Expert input as member of steering committee and chair of working group
Collaborator Contribution Organisational structure and expertise
Impact Open access to database 2013 Publications describing Imaging Enhancment Successful funding for imaging enhancement and set up of new centre
Start Year 2008
 
Description Univ of Siena 
Organisation University of Siena
Department Clinical Neurosciences
Country Italy 
Sector Academic/University 
PI Contribution Research training, software, guidance for new problems
Collaborator Contribution Data, research support
Impact Publications, support for R and D in GlaxoSmith Kline
Start Year 2006
 
Title GlaxoSmithKline Early Development 
Description Over last 5 years, research and group have contributed to development of more than 18 different molecules in early development (see letter from Dr. Phil Murphy in 2013 REF submission). Here these contributions all have been "lumped" into a single entry 
Type Therapeutic Intervention - Drug
Current Stage Of Development Early clinical assessment
Year Development Stage Completed 2013
Development Status Actively seeking support
Impact reducing costs for commercial development, increased competitiveness of UK environment 
 
Description Bard 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact Wrote popular book to highlight brain research- "Bard on the Brain". Follow up lectures. Led to creation of Oxford Centre for the Creative Brain

Multiple public presentation requests inUK, Europe and US
Year(s) Of Engagement Activity 2006,2009,2015
 
Description Consortium of MS Centers Annual Meeting, Montreal 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? Yes
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Health professionals
Results and Impact Consortium of MS Centers Annual Meeting, Montreal, Canada 1 June 2011 - Lessons from brain plasticity in multiple sclerosis

Improved understanding for better care management especially by nurses
Year(s) Of Engagement Activity 2011
 
Description European Dana Alliance 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? Yes
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact Public lectures

Contact for followup book
Year(s) Of Engagement Activity 2006,2007,2008
 
Description London Health Forum 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? Yes
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact 2013 London Health Forum, Korean Healthcare IDI, London, May 2013 - Opportunities for International Collaborative Healthcare Science

Commercial engagement with UK academic base
Year(s) Of Engagement Activity 2013
 
Description U3A Annual Conference 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? Yes
Type Of Presentation Keynote/Invited Speaker
Geographic Reach Regional
Primary Audience Public/other audiences
Results and Impact U3A Annual Conference, East Grinstead, UK - Healthy brain aging

Better informed lay audience
Year(s) Of Engagement Activity 2013